ARQT fundamentals
An in-depth look to Arcutis Biotherapeutics, Inc. operating, investing, and financing activities
ARQT free cash flow for Q1 24 is -31.6 M USD. For 2023, ARQT free cash flow was -247.49 M USD and operating cash flow was -247.06 M USD.
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM